scispace - formally typeset
A

Alexandre Wohlkonig

Researcher at Vrije Universiteit Brussel

Publications -  47
Citations -  2544

Alexandre Wohlkonig is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Ethionamide & Mycobacterium tuberculosis. The author has an hindex of 19, co-authored 46 publications receiving 1975 citations. Previous affiliations of Alexandre Wohlkonig include Université libre de Bruxelles & VU University Amsterdam.

Papers
More filters
Journal ArticleDOI

Characterization of the PAS domain in the sensor-kinase BvgS: mechanical role in signal transmission.

TL;DR: It is proposed that a major function of the BvgS PAS domain is to maintain conformational signals arising from mechanical strain generated by the periplasmic domain.
Journal ArticleDOI

Structural evidence for the critical role of the prion protein hydrophobic region in forming an infectious prion

TL;DR: X-ray crystal structures of mouse (Mo) prion protein (PrP) in complex with a nanobody (Nb484) are reported, providing the first structure-function evidence supporting a crucial role of the hydrophobic region of PrP in forming an infectious prion.
Journal ArticleDOI

The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine/Threonine phosphorylation.

TL;DR: It is demonstrated that the Mycobacterium tuberculosis EthR, a transcriptional repressor that regulates the activation process of the antitubercular drug ethionamide, is a specific substrate of the mycobacterial kinase PknF, and phosphorylation negatively affects its DNA-binding activity, which may impact ETH resistance levels in M. tb.
Journal ArticleDOI

Combining in-situ proteolysis and microseed matrix screening to promote crystallization of PrPc-nanobody complexes.

TL;DR: In-situ proteolysis with automated microseed matrix screening (MMS) is combined to crystallize two different PrP(C)-nanobody (Nb) complexes, which are single-domain antibodies derived from heavy-chain-only antibodies of camelids and could be exploited for the crystallization of other difficult antigen-antibody complexes.